Himuka AM Pharma Corp.
PrivateLast Round
Series B
Jan 14, 2022
Total Funding Raised
$10.67M
Company Overview
Himuka AM Pharma Corp. is a clinical-stage biopharmaceutical company that develops drug candidates based on derivatives of the bioactive peptide adrenomedullin to address unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Himuka AM Pharma Corp. Comparables
Compare Himuka AM Pharma Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Landos Biopharma | 74% | |
| Sorriso Therapeutics | 70% | |
| MRM Health | 66% |
Himuka AM Pharma Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 14, 2022 | ||||
| Series A | Jun 19, 2018 |
Himuka AM Pharma Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Series A |
| Nanto Bank | Series B |
| 日本ベンチャーキャピタル株式会社 | Series A |
| Miyazaki Taiyo Capital | Series B, Series A |
| Venture Labo Investment | Series B |
| Axil Capital Partners | Series A |
| QB Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors grew 40% MoM.
Himuka AM Pharma Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Himuka AM Pharma Corp.'s valuation, stock price, and market status.
Is Himuka AM Pharma Corp. a public or private company?
Himuka AM Pharma Corp. is a private company.
What is the current stock price of Himuka AM Pharma Corp.?
Himuka AM Pharma Corp. is a private company with no public stock price. No recent secondary market data is available.
How much is Himuka AM Pharma Corp. worth (valuation)?
Valuation information for Himuka AM Pharma Corp. is not publicly available.
Can I buy Himuka AM Pharma Corp. stock?
Himuka AM Pharma Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Himuka AM Pharma Corp.'s last funding round?
Himuka AM Pharma Corp.'s most recent funding round was Series B on January 14, 2022.
Who are the main investors in Himuka AM Pharma Corp.?
Key investors in Himuka AM Pharma Corp. include Keio Innovation Initiative, Nanto Bank, 日本ベンチャーキャピタル株式会社, Miyazaki Taiyo Capital, Venture Labo Investment.
Will Himuka AM Pharma Corp. IPO soon?
No public IPO plans have been announced for Himuka AM Pharma Corp..
How can I track Himuka AM Pharma Corp. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Himuka AM Pharma Corp.'s secondary market activity and sign up for updates.